Erythema-based criteria miss skin of color, urging ROSCO phenotyping to improve diagnostic equity in dermatology.
Commentary|Articles|September 2, 2025
New Executive Order Shifts Homeless Policy, Potentially Overwhelming Health Care Services: A Q&A With Kristen R. Choi, PhD, PMHNP-BC, FAAN
Kristen R. Choi, PhD, PMHNP-BC, FAAN, discussed how the new executive order aimed at addressing homelessness could result in adverse consequences.
Advertisement
Advertisement
Kristen R. Choi, Associate Professor & Audrienne H. Moseley Chair in Nursing at UCLA Joe C. Wen School of Nursing & UCLA Fielding School of Public Health, spoke with The American Journal of Managed Care® about the implications of the executive order signed by President Donald Trump aimed at addressing homelessness nationwide.
Related to this article
October's FDA approvals included the introduction of 5 non-oncology treatment options across specialties.
Bipolar disorder often goes undiagnosed for years, and clinicians need to separate mood episodes from normal emotions and keep patients on treatment.
Initial frontal fibrosing alopecia treatment was largely similar in Black and White patients, though tetracycline use was higher in Black patients.
The FDA granted accelerated approval to the first plasmid DNA-based immunotherapy for adults with recurrent respiratory papillomatosis (RRP).
Mayo Clinic case-control study links higher birth weight and childhood obesity to greater non-Hodgkin lymphoma risk, while longer breastfeeding may lower odds.
AI in myeloproliferative neoplasms can grade marrow fibrosis and predict survival, but authors say prospective, outcome-focused trials are needed first.
Costs of multimorbidity in older adults are climbing faster than its disability toll, and study authors say policy should look past single-disease programs.
Advertisement
Advertisement